Invest in the Future of Cardiac Care

At CART-Tech, we are at the forefront of innovation in the electrophysiology field, specialized in a vendor independent platform for image-guidance designed to transform cardiac care. Our advanced technologies are particularly focused on two critical areas: CRT pacemaker implantations and VT ablations. These procedures are vital for patients with complex heart conditions, and our solutions are designed to enhance precision, reduce procedural time, and improve patient outcomes. And all with a scalable, vendor independent platform technology.

Why Invest in CART-Tech?

The vendor independent platform for image-guidance developed by CART-Tech is very scalable and can by used for multiple therapies:

1. Groundbreaking Technology in CRT Pacemaker Implantations

Cardiac Resynchronization Therapy (CRT) pacemakers are essential for treating patients with heart failure. Our image-guided systems provide unmatched accuracy in lead placement, significantly improving the success rates of CRT implants. By integrating 3D heart models with fluoroscopy in real-time during the implantation procedure, we reduce the complexity of these procedures, minimizing risks and enhancing patient recovery.

2. Pioneering Solutions for VT Ablations

Ventricular Tachycardia (VT) is a life-threatening arrhythmia that requires precise and effective treatment. Our technology offers a novel approach to VT ablations, combining high-resolution imaging with advanced mapping systems to identify and target arrhythmic tissue with unparalleled precision. This results in higher success rates and fewer complications, positioning us as leaders in this critical area of cardiac care.

Market Opportunity

The global market for electrophysiology devices is experiencing rapid growth, driven by an aging population and increasing prevalence of cardiac arrhythmias. The CRT and VT ablation markets are expanding at an unprecedented rate, with projections indicating significant growth in the coming years.

• Electrophysiology Market Size: The global electrophysiology market is expected to reach $12.2 billion by 2025, with a CAGR of 10.3% from 2020 to 2025.
• CRT Pacemaker Market: Expected to grow at a CAGR of 7.2% through 2026, driven by advancements in technology and increasing adoption of CRT devices.
• VT Ablation Market: With a CAGR of 11.8%, this market segment is set to see robust growth due to the rising demand for effective arrhythmia management solutions.

Investor Benefits

1. Strong Intellectual Property (IP) and Regulatory Position

Our company holds a robust portfolio of patents, trade secrets and know-how that protect our innovations in image-guided therapy. With a CE-certified product for CRT implantations, and a route to obtain FDA approval we are also on track with regulatory approvals, positioning our products for rapid market entry and adoption. Both providing a strong competitive advantage in the marketplace.

2. Strategic Partnerships

We have established strategic partnerships with leading hospitals, research institutions, and industry players to accelerate the development and adoption of our technologies. These collaborations enhance our market reach and provide valuable clinical insights.

3. Experienced Leadership Team

Our leadership team comprises industry veterans with deep expertise in medical device development, clinical research, and commercialization. Their experience and vision drive our company’s growth and ensure that we remain at the cutting edge of cardiac care technology.

4. Financial Performance

With initial sales and a strong pipeline of new products, CART-Tech is well-positioned to deliver long-term value to our investors. Our financial stability and clear path to profitability make us a compelling investment opportunity.

Join Us in Shaping the Future of Cardiac Care

Invest in CART-Tech and be part of a pioneering journey to revolutionize electrophysiology. Our commitment to innovation, combined with a deep understanding of clinical needs, positions us to lead the next wave of advancements in cardiac care.

For more information on investment opportunities, please contact:

Johan Maas
Email: johan.maas@cart-tech.com

CART-Tech
Innovating for Life, Leading in Cardiac Care